Multifocal fixed drug eruption to ceftazidime in a child with cystic fibrosis

Mansour, A. Ben; Bellon, N.; Frassati-Biaggi, Annonciade; Sermet‐Gaudelus, Isabelle; Ponvert, C.; Blic, J. de; Lezmi, Guillaume

doi:10.1111/pai.12829

Cited by 6 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on the knowledge and positive results achieved, our future patients will benefit from optimized treatment, including a re-challenge assessment in those with milder reactions for better selection of the patients needing the treatment, and shorter schemes, as seen in work carried out by other authors in adult populations. 11,13 In conclusion, we report our 2.5-year experience in paediatric lowgrade glioma patients treated with carboplatin desensitization. We have observed 85.7% prevalence of carboplatin hypersensitivity and obtained 100% success in the 5 patients treated with carboplatin desensitization.…”

Section: Initial Experience With Carboplatin Desensitization: a Case mentioning

confidence: 78%

Initial experience with carboplatin desensitization: A case series in a paediatric hospital

Río

Andión

Ruano

et al. 2017

Pediatric Allergy Immunology

View full text Add to dashboard Cite

Section: Initial Experience With Carboplatin Desensitization: a Case mentioning

confidence: 78%

Initial experience with carboplatin desensitization: A case series in a paediatric hospital

Río

Andión

Ruano

et al. 2017

Pediatric Allergy Immunology

View full text Add to dashboard Cite

“…Multifocal fixed drug eruption to ceftazidime, an unusual presentation of drug allergy in children, has been reported in a child with cystic fibrosis …”

Section: Drug Allergymentioning

confidence: 98%

Food and drug allergy, and anaphylaxis in EAACI journals (2018)

Eigenmann

Akdiş²,

Bousquet

et al. 2019

Pediatric Allergy Immunology

View full text Add to dashboard Cite

The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals: "Allergy," "Pediatric Allergy and Immunology (PAI)," and "Clinical and Translational Allergy (CTA)." One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. This paper summarizes the achievements of 2018 in anaphylaxis, and food and drug allergy. Main topics that have been focused are anaphylaxis, mechanisms of food allergy (FA), epidemiology of FA, food allergens, diagnosis of FA, prevention and control of FA, FA immunotherapy, drug allergy, and political agenda. K E Y W O R D S allergy, anaphylaxis, Clinical and Translational Allergy, drug allergy, European Academy of Allergy and Clinical Immunology, food allergy, hypersensitivity, Pediatric Allergy and Immunology

show abstract

Ceftazidime

2018

Reactions Weekly

View full text Add to dashboard Cite

Multifocal fixed drug eruption to ceftazidime in a child with cystic fibrosis

Cited by 6 publications

References 9 publications

Initial experience with carboplatin desensitization: A case series in a paediatric hospital

Initial experience with carboplatin desensitization: A case series in a paediatric hospital

Food and drug allergy, and anaphylaxis in EAACI journals (2018)

Ceftazidime

Contact Info

Product

Resources

About